MOLECULAR HEALTH PROFILE

EUIPO EUIPO 2016 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark MOLECULAR HEALTH PROFILE was filed as Figurative mark on 05/24/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/21/2016. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Monograms formed of intertwined, overlapping or otherwise combined letters #Letter 'H' #Letter 'M'

Trademark Details Last update: February 8, 2024

Trademark form Figurative mark
File reference 015471535
Application date May 24, 2016
Publication date September 13, 2016
Entry date December 21, 2016
Expiration date May 24, 2026

Trademark owner

Kurfürsten-Anlage 21
69115 Heidelberg
DE

Trademark representatives

Prinzregentenstr. 68 81675 München DE

goods and services

9 Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology; downloadable computer databases containing medical and/ or health information or records about or relating to humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans; downloadable mobile applications for mobile devices, such as eg smart phones and/or tablet computers, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans; medical or laboratory software, including data, databases and algorithms, for DNA and genome analysis in disease diagnostics; medical or laboratory software, including data, databases and algorithms for the diagnosis of genomic changes and tests at the molecular level, in particular laboratory software for next generation sequencing (NGS); laboratory software, including data, databases and algorithms, for next generation sequencing (NGS) in the context of clinical and medical applications, and software, including data, databases and algorithms, for assisting medical or research decisions for diagnostic and therapeutic applications; medical software, including data, databases and algorithms, for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility; laboratory software, including data, databases and algorithms, for high resolution and/or highly sensitive analysis of DNA or genomes; medical or laboratory software, including data, databases and algorithms, for toxicity research in relation to pharmaceutical preparations; medical or laboratory software, including data, databases and algorithms, for analysis of resistance to pharmaceutical preparations;  laboratory device, apparatus and/or equipment for the diagnosis of genomic changes and tests at the molecular level; laboratory device, apparatus and equipment for next generation sequencing (NGS);  laboratory device, apparatus and equipment for next generation sequencing (NGS) in the context of clinical and medical applications, and device, apparatus, equipment and/or instruments for assisting medical or research decisions for diagnostic and therapeutic applications;  laboratory device, apparatus and/or equipment for high resolution and/ or highly sensitive analysis of DNA or genomes
10 Medical or laboratory device, apparatus and/or equipment for DNA and genome analysis in disease diagnostics including but not limited to cancer diagnostics; medical device, apparatus and/or equipment for the diagnosis of genomic changes and tests at the molecular level;  medical device, apparatus and/or equipment for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility;  medical or laboratory device, apparatus and/or equipment for toxicity research in relation to pharmaceutical preparations; medical or laboratory device, apparatus and/or equipment for analysis of resistance to pharmaceutical preparations
38 Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/ or development; providing access to safety information, including an integrated approach to identify the interactions and adverse events related to specific drugs, drug classes, diseases, and molecular targets and pathways; providing access to drug safety information, including relationships between scientific findings and diverse events, including relationships between drugs, toxicity mechanisms, patient susceptibility, and clinical effects, including identification of actual and predicted drug safety concerns; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/ or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing access to databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/ or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes
42 Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and/or pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data, and/or molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, medical and/or health information, records or data, patient specific data, molecular test results, and/or data from clinical studies; scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; designing and/or developing and/or providing use of searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; designing and/or developing and/or providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; designing and/or developing and/or providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, medical and/or health information, records or data, patient specific data, molecular test results, and/or data from clinical studies; scientific research for medical diagnostic and/or treatment research, and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; research or consulting services featuring software under a software as a Service (SaaS) model for enabling the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, patient specific data, molecular test results, and/or data from clinical studies; scientific research and/or health and/or medical information, records or data for medical, diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; conducting molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods; providing services in the field of next generation sequencing (NGS), including analysis and interpretation of the data obtained, in particular data obtained from patients, and analysis and interpretation of changes in his or her genome which contribute to the particular disease of the patient; making available the results of the data analysis and interpretation relating to a patient's genome or the data generated from molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods, including, eg in the form of a report; research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes; providing information in the fields of life sciences, biotechnology, and bioinformatics
44 Consulting services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical information, including information about drug safety and/or drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols; making available the results of the data analysis and interpretation relating to a patient's genome or the data generated from molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods, including, eg in the form of a report, to physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes

Trademark history

Date Document number Area Entry
January 16, 2019 Change Representative, Published
January 16, 2019 Change Representative, Published

ID: 11015471535